Search - tctmd.com

Displaying 601 - 620 of 973

Sort: Relevancy | Date

News Daily News

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

L.A. McKeown

May 07, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

https://stock.adobe.com/images/african-american-girl-brushing-teeth-together-with-dad/247146126

News Daily News

Childhood Oral Infections Linked to Adult Atherosclerosis in Prospective Study

Yael L. Maxwell

April 29, 2019

News Daily News

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

Michael O'Riordan

April 29, 2019

News Daily News

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Michael O'Riordan

April 24, 2019

News Daily News

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

Yael L. Maxwell

April 24, 2019

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

News Daily News

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Yael L. Maxwell

April 18, 2019

News Daily News

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

Michael O'Riordan

April 18, 2019

News Daily News

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Yael L. Maxwell

April 09, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

L.A. McKeown

March 18, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

L.A. McKeown

March 16, 2019

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

News Daily News

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

Michael O'Riordan

February 26, 2019

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

Advertisement

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

TCTMD’s Top 10 Most Popular Stories for April 2019

Childhood Oral Infections Linked to Adult Atherosclerosis in Prospective Study

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

POET: Oral Antibiotics Continue to Show Good Long-term Results for Endocarditis

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content